Medical researchers at Tallaght University Hospital (TUH) have taken part in a ground-breaking Clinical Trial which has discovered that the drug Rucaparib is successful in the treatment of certain prostate cancers.
Collaboration pairs POINT’s expertise in next generation radioligand development and manufacturing with Lantheus’ commercial leadership in PSMA PET and.
Xenetic Biosciences (XBIO) Appoints Jonathan Spicer to its Board streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.